LivaNova

$54.25
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.68 (+1.27%) Today
$0.00 (0.00%) As of 1:56 PM EST after-hours

Why Robinhood?

You can buy or sell LivaNova and other stocks, options, and ETFs commission-free!

About LIVN

LivaNova PLC Ordinary Shares, also called LivaNova, is a global medical technology company, which engages in the development and delivery of important therapeutic solutions for the benefit of patients, healthcare professionals and healthcare systems. It operates through the following segments: Cardiovascular and Neuromodulation. The Cardiovascular segment develops, produces, and sells cardiopulmonary products, heart valves, and advanced circulatory support products. The Neuromodulation segment designs and markets NM-based medical devices for the treatment of epilepsy, depression, and obstructive sleep apnea. The company was founded on February 20, 2015 and is headquartered in London, the United Kingdom. The listed name for LIVN is LivaNova PLC Ordinary Shares.

CEO
Damien McDonald
Employees
4,000
Headquarters
London, Greater London
Founded
2015
Market Cap
2.64B
Price-Earnings Ratio
Dividend Yield
Average Volume
405.41K
High Today
$54.78
Low Today
$53.04
Open Price
$53.78
Volume
247.98K
52 Week High
$85.27
52 Week Low
$33.40

Collections

LIVN Earnings

-$0.30
$0.13
$0.57
$1.00
Q1 FY19
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
per share
Actual
Expected Feb 24, Pre-Market

You May Also Like